|
Volumn 4, Issue 1, 2003, Pages 77-78
|
Hepatitis B virus infection despite receiving Lamivudine in one HIV-infected person
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
HEPATITIS B ANTIGEN;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B VACCINE;
ILLICIT DRUG;
IMMUNOGLOBULIN M;
LAMIVUDINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS ANTIBODY;
VIRUS DNA;
VIRUS RNA;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANTIVIRAL ACTIVITY;
CASE REPORT;
CLINICAL FEATURE;
DISEASE MARKER;
FOLLOW UP;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTRAVENOUS DRUG ABUSE;
LETTER;
MALE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
SERODIAGNOSIS;
VIRUS REPLICATION;
ADULT;
ANTI-HIV AGENTS;
HEPATITIS B;
HIV INFECTIONS;
HUMANS;
LAMIVUDINE;
MALE;
SUBSTANCE-RELATED DISORDERS;
VIRAL VACCINES;
|
EID: 0037226384
PISSN: 15284336
EISSN: None
Source Type: Journal
DOI: 10.1310/6DMU-HEC1-EAX7-RLUN Document Type: Letter |
Times cited : (2)
|
References (6)
|